cilastatin has been researched along with Critical Illness in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fratoni, AJ; Kuti, JL; Mah, JW; Nicolau, DP | 1 |
| Dang, ZL; Li, B; Qin, HY; Rao, Z; Wei, YH; Wu, XA; Zhu, L | 1 |
| Decosterd, LA; Eggimann, P; Fournier, A; Marchetti, O; Pagani, JL; Pannatier, A; Que, YA; Revelly, JP; Voirol, P | 1 |
| Abraham, E; Fish, DN; Teitelbaum, I | 1 |
| Bille, J; Bugnon, D; Cotting, J; Décosterd, L; Giannoni, E; Majcherczyk, P; Moessinger, A; Moreillon, P; Zanetti, G | 1 |
| Bulitta, JB; Drusano, GL; Glauner, AK; Kinzig-Schippers, M; Pfister, W; Sakka, SG; Sörgel, F | 1 |
| Chang, CM; Chuang, YC; Ko, WC; Lee, HC; Lee, NY; Wang, CL; Wang, LR; Yu, WL | 1 |
| Ebira, H; Ikeda, Y; Kihara, M; Masumori, S; Shibata, K; Shionoiri, H; Shiratori, K; Takagi, N; Ueda, S; Umemura, S | 1 |
2 trial(s) available for cilastatin and Critical Illness
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Critical Illness; Drug Therapy, Combination; Female; Hemodiafiltration; Hemofiltration; Humans; Imipenem; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Protease Inhibitors; Renal Replacement Therapy | 2005 |
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Cilastatin; Critical Illness; Cross Infection; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Monte Carlo Method; Protease Inhibitors; Tandem Mass Spectrometry; Treatment Outcome | 2007 |
6 other study(ies) available for cilastatin and Critical Illness
| Article | Year |
|---|---|
Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance.
Topics: Anti-Bacterial Agents; Cilastatin; Critical Illness; Humans; Imipenem | 2022 |
Determination of Total and Unbound Meropenem, Imipenem/Cilastatin, and Cefoperazone/Sulbactam in Human Plasma: Application for Therapeutic Drug Monitoring in Critically Ill Patients.
Topics: Cefoperazone; Chromatography, High Pressure Liquid; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Drug Monitoring; Humans; Imipenem; Meropenem; Plasma; Sulbactam; Tandem Mass Spectrometry | 2020 |
Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Surface Area; Burn Units; Burns; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Computer Systems; Critical Illness; Drug Combinations; Drug Monitoring; Female; Humans; Imipenem; Length of Stay; Male; Meropenem; Middle Aged; Retrospective Studies; Thienamycins; Young Adult | 2015 |
Prospective determination of plasma imipenem concentrations in critically ill children.
Topics: Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Infant, Newborn; Infusions, Intravenous; Male | 2006 |
Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Sulbactam; Taiwan; Thienamycins | 2007 |
Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.
Topics: Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Half-Life; Humans; Imipenem; Infusions, Intravenous; Male; Renal Dialysis; Renal Insufficiency | 1994 |